Sensus Healthcare, Inc.

NASDAQ:SRTS

Medical - Devices

Healthcare
$3.22 +3.05%

+$0.09 today

Market cap
$53.01M
Beta
1.09
P/E (TTM)
-6.5
EPS (TTM)
-$0.47
52W Low $2.66High $5.92

Volume 0.08M

Average 0.06M

SRTS Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Sensus Healthcare, Inc.NASDAQ: SRTS

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 16.46M shares rose 0.9% year over year, ahead of the +0.3% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.8% from the prior quarter. Over 3 fiscal years it compounded at -0.3% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +0.9% holds above the trailing-twelve-month pace of +0.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
16.46M+0.8% QoQ
Last fiscal yearDec 2025
16.33M+0.1% YoY
LTMMar 2026
16.36M+0.3% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.9%——
1 year+0.1%——
3-year CAGR-0.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
16.33M USD
Year-over-year change
+0.1%
4-year CAGR
-0.2%

Weighted Avg Shares vs competitors

How SRTS compares with its peers on the latest reported figures

  • SRTS's LTM Mar 2026 weighted avg shares of 16.36M shares is the 5th highest of the 6 companies compared; the peer median is 28.45M shares.
  • Its year-over-year change of +0.3% is the lowest of 6, against a peer median of +36.3%.
  • Over three fiscal years its annual growth of -0.3% compares with a peer median of +26.1%.
SRTS Competitors Peer median
Weighted Avg Shares for SRTS and competitors
Company Period LTM YoY 3-year CAGR
IPSCCentury Therapeutics, Inc.LTM Mar 202686.45M +4.3%+14.4%
TELATELA Bio, Inc.LTM Jun 202652.94M +36.3%+42.4%
MDAISpectral AI, Inc.LTM Mar 202628.45M +47.3%+14.0%
BDMDBaird Medical Investment Holdings LimitedFY202527.79M +8.8%+64.1%
SRTSSensus Healthcare, Inc.LTM Mar 202616.36M +0.3%-0.3%
KPTIKaryopharm Therapeutics Inc.LTM Mar 202614.32M +72.2%+26.1%
Peer median (excluding SRTS) 28.45M+36.3%+26.1%

Competitors are the stored peer set for SRTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue27.04M44.53M24.41M41.81M27.48M
Cost of Revenue10.05M14.9M10.35M17.38M15.62M
Gross Profit16.99M29.63M14.06M24.43M11.87M
Gross Margin62.8%66.5%57.6%58.4%43.2%
Research & Development3.44M3.46M3.68M4.22M7.78M
Selling, General & Admin9.43M11.34M10.76M12.13M14.4M
Operating Expenses12.87M14.8M14.44M16.34M22.17M
Depreciation & Amortization613K509K461K432K386K
EBITDA4.73M28.5M1.11M9.45M(9.24M)
EBITDA Margin17.5%64.0%4.6%22.6%-33.6%
Operating Income4.12M14.83M(382K)8.09M(10.31M)
Operating Margin15.2%33.3%-1.6%19.4%-37.5%
Interest Income2K382K992K932K683K
Interest Expense1K2K000
Other Income / Expenses(1K)13.16M1.03M932K683K
Income Before Tax4.12M27.99M652K9.02M(9.62M)
Pre-Tax Margin15.2%62.9%2.7%21.6%-35.0%
Income Tax Expense03.75M167K2.38M(1.91M)
Net Income4.12M24.24M485K6.65M(7.72M)
Net Margin15.2%54.4%2.0%15.9%-28.1%
EPS (Basic)0.251.470.030.41(0.47)
EPS (Diluted)0.251.460.030.41(0.47)
Weighted Avg Shares16.48M16.48M16.26M16.31M16.33M
Weighted Avg Shares (Diluted)16.5M16.62M16.27M16.36M16.33M

Sensus Healthcare, Inc.

NASDAQ:SRTS

Intrinsic Alpha fair value

Locked

Current Price

$3.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.